Literature DB >> 33879175

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.

Brendan Le Daré1,2, Christelle Boglione-Kerrien3, Florian Reizine4,5, Jean-Pierre Gangneux6, Astrid Bacle7,6.   

Abstract

Entities:  

Year:  2021        PMID： 33879175     DOI： 10.1186/s13054-021-03568-8

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  4 in total

1.  The impact of proton pump inhibitors on the pharmacokinetics of voriconazole in vitro and in vivo.

Authors:  Miao Yan; Zhu-Feng Wu; Dan Tang; Feng Wang; Yi-Wen Xiao; Ping Xu; Bi-Kui Zhang; Yi-Ping Liu; Da-Xiong Xiang; Hoan Linh Banh
Journal:  Biomed Pharmacother       Date:  2018-09-11       Impact factor: 6.529

2.  Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.

Authors:  Osamu Imataki; Kazunori Yamaguchi; Makiko Uemura; Noriyasu Fukuoka
Journal:  Transpl Infect Dis       Date:  2018-04-10       Impact factor: 2.228

3.  Neglecting Plasma Protein Binding in COVID-19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure.

Authors:  Francoise Stanke-Labesque; Didier Concordet; Zoubir Djerada; Stéphane Bouchet; Caroline Solas; Etienne Mériglier; Fabrice Bonnet; Bruno Mourvillier; Stéphanie Ruiz; Guillaume Martin-Blondel; Olivier Epaulard; Carole Schwebel; Elodie Gautier-Veyret; Peggy Gandia
Journal:  Clin Pharmacol Ther       Date:  2021-03-09       Impact factor: 6.875

Review 4.  Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Authors:  Françoise Stanke-Labesque; Elodie Gautier-Veyret; Stephanie Chhun; Romain Guilhaumou
Journal:  Pharmacol Ther       Date:  2020-07-11       Impact factor: 12.310
  4 in total
  2 in total

1.  COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes.

Authors:  João N de Almeida; André Mario Doi; Maria Julia L Watanabe; Maira Maraghello Maluf; Cecília Leon Calderon; Moacyr Silva; Jacyr Pasternak; Paula Célia M Koga; Kelly Aline S Santiago; Luis Fernando C Aranha; Gilberto Szarf; Gustavo B da Silva Teles; Renée Zon Filippi; Vitor Ribeiro Paes; Marina Baeta; Nelson Hamerschlak; Cristovão Luis P Mangueira; Marines Dalla Valle Martino
Journal:  Mycoses       Date:  2022-02-23       Impact factor: 4.931

2.  Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Sujit Kumar Sah; Atiqulla Shariff; Niharika Pathakamuri; Subramanian Ramaswamy; Madhan Ramesh; Krishna Undela; Malavalli Siddalingegowda Srikanth; Teggina Math Pramod Kumar
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.